Novartis Investigative Site

Nahariya 2210001

2 studies enrolling now · 9 studies all time

What they study most

Acute Heart Failure, Aortic Stenosis, Atherosclerotic Cardiovascular Disease, Behcet Disease, Carcinoma, Renal Cell, Glomerulonephritis, IGA, Heart Failure With Preserved Ejection Fraction, Immunoglobulin A Nephropathy, Leukaemia, Lymphocytic, Chronic, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN — Recruiting now
• A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
• Phase III Study in Refractory Behcet's Disease — Completed